TriangleNCT02793544 · OUTCOME
Cumulative Incidence of Acute GVHD
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- percentage of participants
- Interval / dispersion
- 90% Confidence Interval
- Time frame
- 100 days post-transplant
What was measured
Any skin, gastrointestinal or liver abnormalities fulfilling the BMT CTN Manual of Operations (2013) criteria of grades II-IV acute GVHD. A cumulative incidence will be computed along with a 90% CI. Any skin, gastrointestinal or liver abnormalities fulfilling the BMT CTN Manual of Operations (2013) criteria of grades III-IV acute GVHD. A cumulative incidence will be computed along with a 90% CI.
Groups in this outcome
Myeloablative Conditioning (MAC)
Participants received one of three regimens: cyclophosphamide and total body irradiation; busulfan and cyclophosphamide; or fludarabine and busulfan
Reduced Intensity Conditioning (RIC)
Participants received one of two regimens: fludarabine, cyclophosphamide, and low-dose total body irradiation
| Group | Source count |
|---|---|
| Myeloablative Conditioning (MAC) | 40 |
| Reduced Intensity Conditioning (RIC) | 40 |
Reported measurements
Grades II-IV acute GVHD
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Myeloablative Conditioning (MAC) | 42.5 | Not reported | 29.8 | 55.7 | Not reported |
| Reduced Intensity Conditioning (RIC) | 32.5 | Not reported | 20.9 | 45.3 | Not reported |
Grades III-IV acute GVHD
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Myeloablative Conditioning (MAC) | 17.5 | Not reported | 8.7 | 28.5 | Not reported |
| Reduced Intensity Conditioning (RIC) | 0 | Not reported | 0 | 0 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 29.8
- upper Limit
- 55.7
- value
- 42.5
- group Id
- OG001
- lower Limit
- 20.9
- upper Limit
- 45.3
- value
- 32.5
- title
- Grades II-IV acute GVHD
- categories
- measurements
- group Id
- OG000
- lower Limit
- 8.7
- upper Limit
- 28.5
- value
- 17.5
- group Id
- OG001
- lower Limit
- 0
- upper Limit
- 0
- value
- 0
- title
- Grades III-IV acute GVHD
- denoms
- counts
- group Id
- OG000
- value
- 40
- group Id
- OG001
- value
- 40
- units
- Participants
- description
- Any skin, gastrointestinal or liver abnormalities fulfilling the BMT CTN Manual of Operations (2013) criteria of grades II-IV acute GVHD. A cumulative incidence will be computed along with a 90% CI. Any skin, gastrointestinal or liver abnormalities fulfilling the BMT CTN Manual of Operations (2013) criteria of grades III-IV acute GVHD. A cumulative incidence will be computed along with a 90% CI.
- dispersion Type
- 90% Confidence Interval
- groups
- description
- Participants received one of three regimens: cyclophosphamide and total body irradiation; busulfan and cyclophosphamide; or fludarabine and busulfan
- id
- OG000
- title
- Myeloablative Conditioning (MAC)
- description
- Participants received one of two regimens: fludarabine, cyclophosphamide, and low-dose total body irradiation
- id
- OG001
- title
- Reduced Intensity Conditioning (RIC)
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 100 days post-transplant
- title
- Cumulative Incidence of Acute GVHD
- type
- SECONDARY
- unit Of Measure
- percentage of participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice